Concepedia

Eric Raymond

ER

Statistics

Publications

3

Citations

406

H-Index

3

Active since

1997

Affiliations

Hôpital Paris Saint-Joseph(Current)

Eric Raymond is an author at Hôpital Paris Saint-Joseph specializing in chemotherapy, malignant neoplasms, and cancer pharmacology.

Publications per year

1997–2023

3

Publications

3

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

Jianming Xu, Ken Kato, Eric Raymond et al. · The Lancet Oncology · 2023 · 291 citations

, , +12

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer

Emmanuel Mitry, Pascal Hammel, G. Deplanque et al. · Cancer Chemotherapy and Pharmacology · 2010 · 59 citations

, , +11

Effects of prolonged versus short-term exposure paclitaxel (Taxol??) on human tumor colonyforming units

Eric Raymond, Axel R. Hanauske, Sandrine Faivre et al. · Anti-Cancer Drugs · 1997 · 56 citations

, , +14

1–3 of 3